Virus News and Research

Latest Virus News and Research

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler.

From Quest Diagnostics 12 Apr 2012

Researchers discover a lead on the origin of chronic lymphatic leukaemia

Up until now the causes of the development of chronic lymphatic leukaemia, the most common form of cancer of the blood in Europe, have been unknown. At present a cure is not possible. A research group at the MedUni Vienna led by Christoph Steininger of the University Department of Internal Medicine I has now however discovered a lead on the origin of this disease. Says Steiniger: "This could influence the therapy approach taken in treating chronic lymphatic leukaemia."

12 Apr 2012

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

Winston Pharmaceuticals, Inc.,, announced that the National Institutes of Health has awarded Winston a grant under the Small Business Innovation Research program supporting the development of Civamide, a proprietary TRPV-1 receptor modulator, for the treatment of postherpetic neuralgia of the trigeminal nerve.

9 Apr 2012

State roundup: Health costs cloud forecast for state budgets; Minnesota to use HMO refund on personal care

U.S. state and local governments' fiscal situations have improved recently but will still deteriorate through 2060, the Government Accountability Office said on Thursday. ... The outlook remains gloomy for the future, with healthcare costs, both for public employees and for the Medicaid insurance program for the poor, swelling and weighing on budgets, GAO said.

7 Apr 2012

PloS ONE publishes research on GenVec's new vaccine vectors

GenVec, Inc. announced publication of research on GenVec's new vaccine vectors. These vectors circumvent neutralizing antibodies in order to generate the desired immunologic response.

7 Apr 2012

First Edition: April 6, 2012

Today's early morning highlights from the major news organizations, including the Obama administration's response to a federal court about the Supreme Court's power.

6 Apr 2012

Key data from Boehringer Ingelheim's hepatitis C virus clinical trial programme

Key data from Boehringer Ingelheim's hepatitis C virus (HCV) clinical trial programme, HCVerso, focusing on interferon-free treatment, has been selected for inclusion in the official European Association for the Study of the Liver (EASL) press office activities.

6 Apr 2012

2-day meeting examining issues of censorship of scientific studies leaves questions unanswered

A two-day Royal Society meeting held this week in London -- which examined "whether scientific journals should occasionally publish censored versions of papers because the full ones might prove useful to terrorists" -- "brought scientists no closer to resolving the question of whether there are any kinds of experiments whose results should be kept from the public," the Washington Post reports.

6 Apr 2012

Vaccine injections given directly into pancreatic cancer tumors associated with stable disease

Research from The Cancer Institute of New Jersey (CINJ) shows that a series of vaccine injections given directly into a pancreatic cancer tumor is shown to be associated with stable disease in patients who are not candidates for surgery.

5 Apr 2012

Results from Abbott’s multiple interferon-free Phase 2 HCV studies to be presented at ILC 2012

Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.

5 Apr 2012

Scripps Florida scientists to create new screening tests for HCV treatment discovery

Scientists from the Florida campus of The Scripps Research Institute have been awarded just over $1 million from the National Institutes of Health for a three-year study to develop new high-throughput screening tests to find compounds that disable a protein essential to hepatitis C virus (HCV) replication.

5 Apr 2012

Reactivation of p53 may be a highly selective treatment modality for virally-induced lymphoma

Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis.

4 Apr 2012

Nuvilex realizes important role for Cell-in-a-Box technology

Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions through acquisition of SG Austria assets, realizes the important role for Cell-in-a-Box technology and aims to bring to light its use in the production of therapeutic antibodies for clinically important diseases.

4 Apr 2012

Virus News and Research

Latest Virus News and Research

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Researchers discover a lead on the origin of chronic lymphatic leukaemia

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

State roundup: Health costs cloud forecast for state budgets; Minnesota to use HMO refund on personal care

PloS ONE publishes research on GenVec's new vaccine vectors

First Edition: April 6, 2012

Key data from Boehringer Ingelheim's hepatitis C virus clinical trial programme

2-day meeting examining issues of censorship of scientific studies leaves questions unanswered

Vaccine injections given directly into pancreatic cancer tumors associated with stable disease

Results from Abbott’s multiple interferon-free Phase 2 HCV studies to be presented at ILC 2012

Scripps Florida scientists to create new screening tests for HCV treatment discovery

Reactivation of p53 may be a highly selective treatment modality for virally-induced lymphoma

Nuvilex realizes important role for Cell-in-a-Box technology

MedImmune's quadrivalent flu vaccine may protect children

Scientists discover new anti-HCV antibodies

SFU receives NIH grant to develop effective HIV/AIDS vaccine

Young girls face increased risk of side effects after Gardasil vaccination

Combination of carboplatin, paclitaxel and RT3D shows promise against head and neck cancer

Funding shortfalls could hinder implementation of treatment as prevention strategies, Al Jazeera reports

Positive outcome from AiCuris’ Letermovir phase 2b trial on HCMV infections

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in